Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F6Y5W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,423
Award facts
- Contract value 100% obligated
- $25,423.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25,423.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 30, 2026, for Cosentyx (secukinumab) 300mg dose in 2-pen per milliliter formulation. This is a non-set-aside competitive award with an ultimate completion date of February 2, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a single-award vehicle valued at $999,999,999.00 through December 2026 that serves as the primary mechanism for pharmaceutical and medical supply delivery to military healthcare programs worldwide.
AmerisourceBergen is a major pharmaceutical distributor that holds a critical position in the federal medical supply chain, particularly for Department of Defense healthcare systems. The company supplies a comprehensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to military treatment facilities, the Defense Health Agency, U.S. Coast Guard, and other federal medical institutions. This delivery order for Cosentyx, a specialty medication used in immunological and rheumatological treatments, exemplifies the company's role in providing essential pharmaceutical commodities to support federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F6Y5W?
SPE2DR26F6Y5W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F6Y5W worth?
The government has obligated $25,423 on SPE2DR26F6Y5W.
Is contract SPE2DR26F6Y5W an order under another contract?
Yes. SPE2DR26F6Y5W is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6Y5W competed?
The extent of competition for SPE2DR26F6Y5W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award